ULK1 and acute myeloid leukemia: In this study, we evaluated the effects of the ULK1 inhibitors MRT 68921 and SBI-0206965 on apoptosis, and the potential of therapeutic strategies involving ULK1 targeting in FLT3-ITD AML cells.